Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Standardaero, SLNO, Weride Inc-, Pony Ai, PHAT, and represent 97.36% of Carlyle Group's stock portfolio.
- Added to shares of these 9 stocks: Standardaero (+$3.9B), Weride Inc- (+$49M), Pony Ai (+$34M), XCUR, Onkure Therapeutics Inc-a, REPX, HOOD, METC, SMHI.
- Started 7 new stock positions in METC, REPX, Pony Ai, Onkure Therapeutics Inc-a, Standardaero, HOOD, Weride Inc-.
- Reduced shares in these 10 stocks: QDEL (-$377M), SLNO (-$121M), ZI (-$120M), CSLR (-$5.2M), RPHM, SWI, GETY, AVGO, CART, MTEM.
- Sold out of its positions in AVGO, QDEL, MTEM, RPHM, SWI, ZI.
- Carlyle Group was a net buyer of stock by $3.3B.
- Carlyle Group has $4.1B in assets under management (AUM), dropping by 334.81%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Carlyle Group
Carlyle Group holds 27 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Standardaero | 93.2 | $3.9B | NEW | 6.7M | 579.24 |
|
| Soleno Therapeutics (SLNO) | 1.5 | $62M | -66% | 1.4M | 44.89 |
|
| Weride Sponsored Ads | 1.2 | $49M | NEW | 3.4M | 14.18 |
|
| Pony Ai Sponsored Ads | 0.8 | $34M | NEW | 2.4M | 14.35 |
|
| Phathom Pharmaceuticals (PHAT) | 0.7 | $28M | 3.5M | 8.12 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.5 | $23M | 1.1M | 21.26 |
|
|
| Getty Images Holdings Cl A Com (GETY) | 0.5 | $19M | -5% | 8.7M | 2.16 |
|
| Invitation Homes (INVH) | 0.4 | $15M | 478k | 31.97 |
|
|
| Cubesmart (CUBE) | 0.2 | $9.4M | 221k | 42.85 |
|
|
| Seacor Marine Hldgs (SMHI) | 0.2 | $8.9M | 1.4M | 6.56 |
|
|
| Forward Air Corporation (FWRD) | 0.1 | $4.1M | 107k | 38.26 |
|
|
| Exicure (XCUR) | 0.1 | $3.8M | +399% | 282k | 13.67 |
|
| Hillevax (HLVX) | 0.1 | $3.8M | 1.8M | 2.08 |
|
|
| Q32 Bio (QTTB) | 0.1 | $3.8M | 1.1M | 3.43 |
|
|
| Complete Solaria (CSLR) | 0.1 | $3.6M | -59% | 2.0M | 1.79 |
|
| Smart Sh Global Ads (EM) | 0.1 | $3.5M | 4.8M | 0.72 |
|
|
| Krispy Kreme (DNUT) | 0.1 | $3.4M | 341k | 9.93 |
|
|
| Adicet Bio (ACET) | 0.1 | $2.8M | 2.9M | 0.96 |
|
|
| Onkure Therapeutics Com Cl A | 0.1 | $2.3M | NEW | 270k | 8.62 |
|
| Spruce Biosciences (SPRB) | 0.0 | $1.2M | 2.9M | 0.42 |
|
|
| N-able Common Stock (NABL) | 0.0 | $876k | 94k | 9.34 |
|
|
| Maplebear (CART) | 0.0 | $340k | -39% | 8.2k | 41.42 |
|
| Riley Exploration Permian In (REPX) | 0.0 | $315k | NEW | 9.9k | 31.92 |
|
| Robinhood Mkts Com Cl A (HOOD) | 0.0 | $233k | NEW | 6.2k | 37.26 |
|
| Spyre Therapeutics Com New (SYRE) | 0.0 | $224k | 9.6k | 23.26 |
|
|
| Ramaco Res Com Cl A (METC) | 0.0 | $201k | NEW | 20k | 10.26 |
|
| Nucana Sponsored Adr (NCNA) | 0.0 | $159k | 133k | 1.19 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2024 Q4 filed Feb. 13, 2025
- Carlyle Group 2024 Q3 filed Nov. 8, 2024
- Carlyle Group 2024 Q2 filed Aug. 9, 2024
- Carlyle Group 2024 Q1 filed May 3, 2024
- Carlyle Group 2023 Q4 filed Feb. 2, 2024
- Carlyle Group 2023 Q3 filed Nov. 3, 2023
- Carlyle Group 2023 Q2 filed Aug. 4, 2023
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022
- Carlyle Group 2022 Q2 filed Aug. 12, 2022
- Carlyle Group 2022 Q1 filed May 13, 2022
- Carlyle Group 2021 Q4 filed Feb. 11, 2022
- Carlyle Group 2021 Q3 filed Nov. 12, 2021
- Carlyle Group 2021 Q2 filed Aug. 12, 2021
- Carlyle Group 2021 Q1 filed May 14, 2021